DITROPAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ditropan, and when can generic versions of Ditropan launch?
Ditropan is a drug marketed by Ortho Mcneil Janssen and Janssen Pharms and is included in three NDAs.
The generic ingredient in DITROPAN is oxybutynin chloride. There are sixteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ditropan
A generic version of DITROPAN was approved as oxybutynin chloride by TEVA PHARMS USA on November 14th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DITROPAN?
- What are the global sales for DITROPAN?
- What is Average Wholesale Price for DITROPAN?
Summary for DITROPAN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 22 |
| Patent Applications: | 4,901 |
| Drug Prices: | Drug price information for DITROPAN |
| What excipients (inactive ingredients) are in DITROPAN? | DITROPAN excipients list |
| DailyMed Link: | DITROPAN at DailyMed |
Recent Clinical Trials for DITROPAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Il-Yang Pharm. Co., Ltd. | Phase 2 |
| Seoul National University Hospital | Phase 2 |
| Brigham and Women's Hospital | Phase 2 |
US Patents and Regulatory Information for DITROPAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Janssen | DITROPAN | oxybutynin chloride | SYRUP;ORAL | 018211-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Janssen Pharms | DITROPAN XL | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 020897-002 | Dec 16, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Janssen Pharms | DITROPAN | oxybutynin chloride | TABLET;ORAL | 017577-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Janssen Pharms | DITROPAN XL | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 020897-001 | Dec 16, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Janssen Pharms | DITROPAN XL | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 020897-003 | Jun 22, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
